Collaboration Station

Where CMI, Compas, Singularity, InfoCures, & MEDtrak Come Together!

Join the Debate: DTC Ads Should Do More Than Raise Eyebrows November 18, 2013

Filed under: Corporate — CMI/Compas @ 6:35 pm

In an important article published, we address the pervasive issue of DTC advertising criticism, most recently discussed in a highly debated New York Times Article. MM&M has published CMI/Compas’ response to recent reports that address criticism of pharmaceutical advertising, naming it a source of “invented patient conditions” and “excessive and inappropriate drug use.”

MM&M Web Exclusive: Click Here
New York Times article: Click Here

For a free copy of the original CMI/Compas research into physician preferences of DTC marketing, please contact Lindsay Dinan at


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s